P489 How often is dose escalation needed in patients with inflammatory bowel disease treated with anti-TNF?
Autor: | Viazis, N., Koukouratos, T., Saprikis, E., Al-Odat, M., Anastasopoulos, E., Zacharakis, G., Karamanolis, D. |
---|---|
Zdroj: | In Journal of Crohn's and Colitis February 2013 7 Supplement 1:S206-S206 |
Databáze: | ScienceDirect |
Externí odkaz: |